Generation of Helicobacter pylori ghosts by PhiX protein E-mediated inactivation and their evaluation as vaccine candidates

Infection and Immunity

Volumn 71, Issue 1, 2003, Pages 109-116

  Panthel, Klaus ^a   Jechlinger, Wolfgang ^c   Matis, Alexander ^c   Rohde, Manfred ^b   Szostak, Michael ^d   Lubitz, Werner ^c,d   Haas, Rainer ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c UNIVERSITY OF VIENNA   (Austria)

^d Bird C GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; VACCINE;

ANIMAL MODEL; ARTICLE; BACTERIAL MEMBRANE; BACTERIOPHAGE PHI X 174; BACTERIUM CONJUGATION; CHEMICAL ANALYSIS; E GENE; ESCHERICHIA COLI; FEMALE; GENE; GENE CASSETTE; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHUTTLE VECTOR; TEMPERATURE; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; BACTERIOLYSIS; BACTERIOPHAGE PHI X 174; CELL MEMBRANE; CONJUGATION, GENETIC; ESCHERICHIA COLI; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; MICE; MICE, INBRED BALB C; PLASMIDS; TRANSFORMATION, BACTERIAL; VIRAL PROTEINS;

EID: 0037220187     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.1.109-116.2003     Document Type: Article

References (51)

1. Aebischer, T., S. Laforsch, R. Hurwitz, F. Brombacher, and T. F. Meyer. 2001. Immunity against Helicobacter pylori: Significance of interleukin-4 receptor α chain status and gender of infected mice. Infect. Immun. 69:556-558.
2. Bereswill, S., U. Waidner, S. Odenbreit, F. Lichte, F. Fassbinder, G. Bode, and M. Kist. 1998. Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology 144:2505-2516.
3. Bernhardt, T. G., W. D. Roof, and R. Young. 2000. Genetic evidence that the bacteriophage phi X174 lysis protein inhibits cell wall synthesis. Proc. Natl. Acad. Sci. USA 97:4297-4302.
4. Bumann, D., W. G. Metzger, E. Mansouri, O. Palme, M. Wendland, R. Hurwitz, G. Haas, T. Aebischer, B. von Specht, and T. F. Meyer. 2001. Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers. Vaccine 20:845-852.
5. Corthésy-Theulaz, I., N. Porta, M. Glauser, E. Saraga, A. C. Vaney, R. Haas, J. P. Kraehenbuhl, A. L. Blum, and P. Michetti. 1995. Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology. 109:115-121.
6. c expressing urease A and B subunits. Infect. Immun. 66:581-586.
7. Czinn, S. J., A. Cai, and J. G. Nedrud. 1993. Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunization. Vaccine 11:637-642.
8. Czinn, S. J., and J. G. Nedrud. 1991. Oral immunization against Helicobacter pylori. Infect. Immun. 59:2359-2363.
9. Dehio, C., and M. Meyer. 1997. Maintenance of broad-host-range incompatibility group P and group Q plasmids and transposition of Tn5 in Bartonella henselae following conjugal plasmid transfer from Escherichia coli. J. Bacteriol. 179:538-540.
10. Del Giudice, G., A. Covacci, J. L. Telford, C. Montecucco, and R. Rappuoli. 2001. The design of vaccines against Helicobacter pylori and their development. Annu. Rev. Immunol. 19:523-563.
11. DiPetrillo, M. D., T. Tibbetts, H. Kleanthous, K. P. Killeen, and E. L. Hohmann. 1999. Safety and immunogenicity of phoP/phoQ-deleted Salmonella typhi expressing Helicobacter pylori urease in adult volunteers. Vaccine 18:449-459.
12. Doidge, C., I. Gust, A. Lee, F. Buck, S. Hazell, and U. Manne. 1994. Therapeutic immunisation against Helicobacter infection. Lancet 343:914-915.
13. Ferguson, M., D. J. Wood, and P. D. Minor. 1993. Antigenic structure of poliovirus in inactivated vaccines. J. Gen. Virol. 74:685-690.
14. Ferrero, R. L., J.-M. Thiberge, M. Huerre, and A. Labigne. 1994. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: Evidence of protection in a mouse model of gastric infection. Infect. Immun. 62:4981-4989.
15. Fischer, W., D. Schwan, E. Gerland, G. E. Erlenfeld, S. Odenbreit, and R. Haas. 1999. A plasmid-based vector system for the cloning and expression of Helicobacter pylori genes encoding outer membrane proteins. Mol. Gen. Genet. 262:501-507.
16. Forman, D., D. G. Newell, F. Fullerton, J. W. G. Yarnell, A. R. Stacey, N. Wald, and F. Sitas. 1991. Association between infection with Helicobacter pylori and risk of gastric cancer - Evidence from a prospective investigation. Br. Med. J. 302:1302-1305.
17. Gomez-Duarte, O. G., B. Lucas, Z. X. Yan, K. Panthel, R. Haas, and T. F. Meyer. 1998. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella typhimurium producing urease subunits A and B. Vaccine 16:460-471.
18. Haas, R., T. F. Meyer, and J. P. M. van Putten. 1993. Aflagellated mutants of Helicobacter pylori generated by genetic transformation of naturally competent strains using transposon shuttle mutagenesis. Mol. Microbiol. 8:753-760.
19. Hensel, A., V. Huter, A. Katinger, P. Raza, C. Strnistschie, U. Roesler, E. Brand, and W. Lubitz. 2000. Intramuscular immunization with genetically inactivated (ghosts) Actinobacillus pleuropneumoniae serotype 9 protects pigs against homologous aerosol challenge and prevents carrier state. Vaccine 18:2945-2955.
20. Heuermann, D., and R. Haas. 1998. A stable shuttle vector system for efficient genetic complementation of Helicobacter pylori strains by transformation and conjugation. Mol. Gen. Genet. 257:519-528.
21. Ilver, D., A. Arnqvist, J. Ogren, I. M. Frick, D. Kersulyte, E. T. Incecik, D. E. Berg, A. Covacci, L. Engstrand, and T. Borén. 1998. Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging. Science 279:373-377.
22. Jechlinger, W., M. P. Szostak, A. Witte, and W. Lubitz. 1999. Altered temperature induction sensitivity of the lambda pR/cI857 system for controlled gene E expression in Escherichia coli. FEMS Microbiol. Lett. 173:347-352.
23. Kato, M., Y. Yamaoka, J. J. Kim, R. Reddy, M. Asaka, K. Kashima, M. S. Osato, F. A. K. El-Zaatari, D. Y. Graham, and D. H. Kwon. 2000. Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter priori isolates from Japan. Antimicrob. Agents Chemother. 44:2214-2216.
24. Kotloff, K. L., M. B. Sztein, S. S. Wasserman, G. A. Losonsky, S. C. DiLorenzo, and R. 1. Walker. 2001. Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection. Infect. Immun. 69:3581-3590.
25. Labigne, A., V. Cussac, and P. Courcoux. 1991. Shuttle cloning and nucleotide sequences of Helicobacter pylori genes responsible for urease activity. J. Bacteriol. 173:1920-1931.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227:680-685.
27. Lee, A., and M. Chen. 1994. Successful immunization against gastric infection with Helicobacter species: Use of a cholera toxin B-subunit-whole-cell vaccine. Infect. Immun. 62:3594-3597.
28. Lee, C. K., R. Weltzin, W. D. Thomas, H. Kleanthous, T. H. Ermak, G. Soman, J. E. Hill, S. K. Ackerman, and T. P. Monath. 1995. Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J. Infect. Dis. 172:161-172.
29. Marchetti, M., B. Arico, D. Burroni, N. Figura, R. Rappuoli, and P. Ghiara. 1995. Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 267:1655-1658.
30. Marchetti, M., M. Rossi, V. Giannelli, M. M. Giuliani, M. Pizza, S. Censini, A. Covacci, P. Massari, C. Pagliaccia, R. Manetti, J. L. Telford, G. Douce, G. Dougan, R. Rappuoli, and P. Ghiara. 1998. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 16:33-37.
31. Michetti, P., I. Corthesy-Theulaz, C. Davin, R. Haas, A. C. Vaney, M. Heitz, J. Bille, J. P. Kraehenbuhl, E. Saraga, and A. L. Blum. 1994. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 107:1002-1011.
32. Michetti, P., and R. Haas. 1994. Steps towards a vaccine, p. 53-57. In P. Malfertheiner, F. Megraud, P. Michetti, and A. Price (ed.), The Year in Helicobacter Pylori 1994. Current Science, Ltd., London, United Kingdom.
33. Michetti, P., C. Kreiss, K. L. Kotloff, N. Porta, J. L. Blanco, D. Bachmann, M. Herranz, P. F. Saldinger, I. Corthesy-Theulaz, G. Losonsky, R. Nichols, J. Simon, M. Stolte, S. Ackerman, T. P. Monath, and A. L. Blum. 1999. Oral immunization with urease and Escherichia coli heat-labile enterotoxin is safe and immunogenic in Helicobacter pylori-infected adults. Gastroenterology 116:804-812.
34. Nencioni, L., M. Pizza, M. Bugnoli, T. De Magistris, A. Di Tommaso, F. Giovannoni, R. Manetti, I. Marsili, G. Matteucci, D. Nucci, R. Olivieri, P. Pileri, R. Presentini, L. Villa, J. G. Kreeftenberg, S. Silvestri, A. Tagliabue, and R. Rappuoli. 1990. Characterization of genetically inactivated pertussis toxin mutants: Candidates for a new vaccine against whooping cough. Infect. Immun. 58:1308-1315.
35. Nomura, A., G. N. Stemmermann, P. H. Chyou, I. Kato, G. I. Perez-Perez, and M. J. Blaser. 1991. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N. Engl. J. Med. 325:1132-1136.
36. Odenbreit, S., J. Püls, B. Sedlmaier, E. Gerland, W. Fischer, and R. Haas. 2000. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287:1497-1500.
37. Odenbreit, S., M. Till, D. Hofreuter, G. Faller, and R. Haas. 1999. Genetic and functional characterisation of the alpAB gene locus essential for adhesion of Helicobacter pylori to human gastric tissue. Mol. Microbiol. 31:1537-1548.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
39. Schmitt, W., S. Odenbreit, D. Heuermann, and R. Haas. 1995. Cloning of the Helicobacter pylori recA gene and functional characterization of its product. Mol. Gen. Genet. 248:563-572.
40. Schutze, K., E. Hentschel, B. Dragosics, and A. M. Hirschl. 1995. Helicobacter pylori reinfection with identical organisms: Transmission by the patients' spouses. Gut 36:831-833.
41. Sipponen, P. 1992. Natural history of gastritis and its relationship to peptic ulcer disease. Digestion 51:70-75.
42. Spurr, A. R. 1969. A low-viscosity epoxy resin embedding medium for electron microscopy. J. Ultrastruct. Res. 26:31-43.
43. Stolte, M., and S. Eidt. 1993. Healing gastric MALT lymphomas by eradicating H. pylori. Lancet 342:568.
44. Sutton, P., and A. Lee. 2000. Review article: Helicobacter pylori vaccines - The current status. Aliment. Pharmacol. Ther. 14:1107-1118.
45. Sutton, P., J. Wilson, and A. Lee. 2000. Further development of the Helicobacter pylori mouse vaccination model. Vaccine 18:2677-2685.
46. Szostak, M. P., A. Hensel, F. O. Eko, R. Klein, T. Auer, H. Mader, A. Haslberger, S. Bunka, G. Wanner, and W. Lubitz. 1996. Bacterial ghosts: Non-living candidate vaccines. J. Biotechnol. 44:161-170.
47. Taylor, D. N., and M. J. Blaser. 1991. The epidemiology of Helicobacter pylori infection. Epidemiol. Rev. 13:42-59.
48. Trebesius, K., K. Panthel, S. Strobel, K. Vogt, G. Faller, T. Kirchner, M. Kist, J. Heesemann, and R. Haas. 2000. Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut 46:608-614.
49. Valentine, R. C., B. M. Shapiro, and E. R. Stadtman. 1968. Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli. Biochemistry 7:2143-2152.
50. Weltzin, R., H. Kleanthous, F. Guirakhoo, T. P. Monath, and C. K. Lee. 1997. Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infection. Vaccine 15:370-376.
51. Witte, A., G. Wanner, U. Blasi, G. Halfmann, M. Szostak, and W. Lubitz. 1990. Endogenous transmembrane tunnel formation mediated by φ bX174 lysis protein E. J. Bacteriol. 172:4109-4114.